Further expanding the phenotype of anti-Ku antibody associated disease in children and adolescents
Neuromuscular Disorders · 2024
DOI: 10.1016/j.nmd.2024.05.008 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neuromuscular Disorders, 2024. Verfasst von Ezgi Deniz Batu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Electronic address: ezgideniz…. Hauptthemen laut MEDLINE: Phenotype, Ku Autoantigen, Autoantibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Anti-Ku autoantibodies are associated with several autoimmune inflammatory diseases. We aimed to review our anti-Ku positive pediatric patients in this study. Four pediatric patients (all female) who had anti-Ku positivity were included (Patients 1-2-3 with idiopathic inflammatory myopathy (IIM); Patient 4 with chronic urticaria). Patient 1 (onset:10.5 years) had proximal muscle weakness, Raynaud phenomenon, sclerodactyly, hyperpigmentation, joint contracture, and tenosynovitis. The disease course was progressive despite treatment with corticosteroids, intravenous immunoglobulin (IVIG), plasma exchange, and 11 different immunosuppressive drugs. Patient 2 (onset:15 years) presented with proximal muscle weakness, fatigue, weight loss. She recovered normal muscle strength after treatment with corticosteroids, IVIG, methotrexate, cyclosporine A, mycophenolate mofetil. Patient 3 (onset:10 years) had juvenile dermatomyositis with proximal muscle weakness, Gottron's papules, and calcinosis. She also had anti-NXP2 positivity. Remission was achieved with corticosteroids, methotrexate, azathioprine, and infliximab. Muscle biopsy findings revealed a variable spectrum of necrosis, regeneration, perifascicular pattern, and inflammation. Patient 4 had only chronic urticaria (onset: 6.5 years). The striking features of this series were heterogeneity in clinical presentations including solely chronic urticaria and IIM; variable response to immunosuppressive treatments; and histopathology revealing a spectrum of necrosis, regeneration and inflammatory infiltration. Expanding the spectrum of anti-Ku positivity will allow better understanding of anti-Ku-associated phenotype clusters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Pediatric Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Electronic address: ezgidenizbatu@yahoo.com.
- Department of Pediatrics, Division of Pediatric Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
- Department of Pediatrics, Division of Pediatric Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
- Department of Pediatrics, Pathology Unit, Hacettepe University Faculty of Medicine, Ankara, Turkey.
- Department of Medical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
- Department of Pediatrics, Division of Pediatric Allergy and Immunology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Zitieren
APA
Batu, E. D., Şener, S., Haliloğlu, G., Talim, B., Şener, B., Şahiner, Ü. M., Bilginer, Y., Orhan, D., Aydıngöz, Ü., & Özen, S. (2024). Further expanding the phenotype of anti-Ku antibody associated disease in children and adolescents. Neuromuscular Disorders. https://doi.org/10.1016/j.nmd.2024.05.008
Vancouver
Batu ED, Şener S, Haliloğlu G, Talim B, Şener B, Şahiner ÜM, et al. Further expanding the phenotype of anti-Ku antibody associated disease in children and adolescents. Neuromuscular Disorders. 2024. doi:10.1016/j.nmd.2024.05.008
BibTeX
@article{Batu2024,
author = {Batu, Ezgi Deniz and Şener, Seher and Haliloğlu, Göknur and Talim, Beril and Şener, Burçin and Şahiner, Ümit Murat and Bilginer, Yelda and Orhan, Diclehan and Aydıngöz, Üstün and Özen, Seza},
title = {Further expanding the phenotype of anti-Ku antibody associated disease in children and adolescents},
journal = {Neuromuscular Disorders},
year = {2024},
doi = {10.1016/j.nmd.2024.05.008}
}
EUVIMED